Leucinamide hydrochloride → N-[N-(3,4-dichlorophenyl)-L-alanyl]-L-leucine amide

HRID 2299545

Reaktionsgleichung

Reaktionsgleichung von HRID 2299545
Cl.[NH2:2][C@H:3]([C:8]([NH2:10])=[O:9])[CH2:4][CH:5]([CH3:7])[CH3:6].[Cl:11][C:12]1[CH:13]=[C:14]([NH:19][CH:20]([C:22](O)=[O:23])[CH3:21])[CH:15]=[CH:16][C:17]=1[Cl:18]>>[Cl:11][C:12]1[CH:13]=[C:14]([NH:19][C@H:20]([C:22]([NH:10][C:8](=[O:9])[C@H:3]([CH2:4][CH:5]([CH3:7])[CH3:6])[NH2:2])=[O:23])[CH3:21])[CH:15]=[CH:16][C:17]=1[Cl:18]

Komponenten

3

Versuchsvorschrift

Following General Procedure D and using L-leucinamide hydrochloride (Sigma) and N-(3,4-dichlorophenyl)-D,L-alanine (from Example A above), the title compound was prepared. This compound was then purified by column chromatography, eluted first with 1:1 EtOAc/hexane, then with 5% MeOH in methylene chloride.

Aufarbeitung

  1. customThis compound was then purified by column chromatography
  2. washeluted first with 1:1 EtOAc/hexane

Quellen und Nachweise

ORD-Eintrag
ord-668fd6c6dc1c48f9a0e4a10c089d4849
Quelldatensatz
uspto-grants-2002_12
Patentnummer
US06495693B2

Verknüpfte Notizen

Wird geladen…